HIV status alters immune cell infiltration and activation profile in women with breast cancer

The breast cancer (BC)-related mortality is higher and the immunity is altered in women living with HIV (WLWH) compared to HIV-negative women. Therefore, tumor samples of 296 black BC patients from South Africa and Namibia with known age, HIV status, tumor stage, hormone receptor and HER2 status and...

Full description

Saved in:
Bibliographic Details
Published inNature communications Vol. 16; no. 1; pp. 4699 - 14
Main Authors Bauer, Marcus, Santos, Pablo, Wilfer, Andreas, van den Berg, Eunice, Zietsman, Annelle, Vetter, Martina, Kaufhold, Sandy, Wickenhauser, Claudia, dos-Santos-Silva, Isabel, Chen, Wenlong Carl, Cubasch, Herbert, Murugan, Nivashini, McCormack, Valerie, Joffe, Maureen, Seliger, Barbara, Kantelhardt, Eva
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 20.05.2025
Nature Publishing Group
Nature Portfolio
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The breast cancer (BC)-related mortality is higher and the immunity is altered in women living with HIV (WLWH) compared to HIV-negative women. Therefore, tumor samples of 296 black BC patients from South Africa and Namibia with known age, HIV status, tumor stage, hormone receptor and HER2 status and overall survival (OS) are analyzed for components of the tumor microenvironment (TME). WLWH ( n  = 117), either with suppressed viral activity (HR = 1.25) or with immune suppression (HR = 2.04), have a shorter OS. HIV status is associated with increased numbers of CD8 + T cells in the TME compared to HIV-negative patients; no correlation is found with CD4 + T cell numbers in the blood. Moreover, an increased expression of CD276/B7-H3 and a more pronounced IFN-γ signaling in the tumors are found in WLWH, independent of age, stage, and BC subtypes. In conclusion, altered T cell composition and CD276 expression in WLWH may contribute to inferior survival and can be used for targeted treatment. Cancer is subject to immune surveillance, and HIV infection dampens immune capacity, but HIV-induced immune alterations in patients with breast cancer is still unclear. Here the authors profile women living with HIV to find increased CD8 T cell tumor infiltration, enhanced checkpoint molecular expression, and reduced overall survival when compared with controls.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:2041-1723
2041-1723
DOI:10.1038/s41467-025-59408-8